Acquisitions (Schedule of Acquisition Consideration) (Details)		0 Months Ended
	Feb. 28, 2014	Feb. 28, 2014 Paladin Labs Inc. [Member] USD ($)	Feb. 28, 2014 Paladin Labs Inc. [Member] CAD
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Number of Paladin Shares paid in cash		20,765,000	20,765,000
Exchange ratio		1.6331	1.6331
Number of shares of Endo International common stock—as exchanged		33,912,000	33,912,000
Endo common stock price		$ 80.00
Fair value of common shares of Endo International issued to Paladin Shareholders		$ 2,700,000,000
Per share cash consideration for Paladin shares		$ 1.09	1.16
Cash distribution to Paladin shareholders		22,647,000
Fair value of the vested portion of Paladin stock options outstanding		131,323,000
Total acquisition consideration		$ 2,866,926,000
Exchange Rate	0.9402
Number of vested Paladin stock options outstanding		1,300,000.0	1,300,000.0